Why is the comparison with Medicare for NIMODIPINE 30 MG CAPSULE labelled estimated?

Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Nimodipine / Nimodipine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.

NIMODIPINE 30 MG CAPSULE

For 30 capsules

Pharmacies pay

$41.08 filed

30 × $1.36945 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$78.71 filed

30 × $2.62361 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

1.9× estimated

Medicare paid 1.9× what pharmacies pay.

Part D averages every strength and form sold under “Nimodipine” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$52.24 estimated

$41.08 + $6.16 (15%) + $5.00 fee per fill = $52.24

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

NIMODIPINE 30 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as nimodipine.

FDA gives its dosage form as capsule, liquid filled and its route as oral.

Its labelers, the companies named on the label, are Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and BIONPHARMA INC.

FDA’s Established Pharmacologic Class for it is Dihydropyridine Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes); the FDA directory lists 4 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $41.08 for 30 capsules (30 × $1.36945 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 capsules · NADAC explanation codes

All 5 NDCs

23155-0512-00 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $1.36945 per EA · eff. 2026-09-23 filed
23155-0512-30 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $1.36945 per EA · eff. 2026-09-23 filed
69452-0209-07 · not listed as a package in the FDA directory · $1.36945 per EA · eff. 2026-09-23 filed
69452-0209-13 · BIONPHARMA INC. · $1.36945 per EA · eff. 2026-09-23 filed
69452-0209-20 · BIONPHARMA INC. · $1.36945 per EA · eff. 2026-09-23 filed

Compared with its class

The middle of its 5 NDCs’ NADAC prices is $1.36945 per EA filed.

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 29 have a higher middle NADAC price and 38 a lower one. The one in the middle is NICARDIPINE 20 MG CAPSULE, at $1.12012 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $78.71 for 30 capsules, at an average of $2.62361 per EA in 2024 (2024-01-01 to 2024-12-31) for “Nimodipine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,342 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.

Questions

Why is the comparison with Medicare for NIMODIPINE 30 MG CAPSULE labelled estimated?: Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Nimodipine / Nimodipine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.

Its pharmacologic class

Dihydropyridine Calcium Channel Blocker 70 products